You're reading the free version. Trader adds the live tape and alerts.
Start tracking
GRTX Disposition Disclosure
Sorensen Mel · SEC Form 4 · Filed Aug 5, 2026
Disposition
Reported value range
Not reported
Sorensen Mel President And CEO
GRTX
Transaction date
Aug 3, 2026
Public filing date
Aug 5, 2026
Filing lag
Filed 2 days later
GRTX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 30,000 shares
- SEC ownership
- Direct
- Transaction code
- D
- Form
- 4
- Filing identifier
- 0001193125-26-335499
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
Not reported
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Galera Therapeutics, Inc. GRTX | Disposition | Aug 3, 2026 | Not reported |
| Galera Therapeutics, Inc. GRTX Current | Disposition | Aug 3, 2026 | Not reported |